Progress is being made on Hep C but more action needs to be taken
08 August 2014
Blenheim welcomes the publication of Hepatitis C in the UK 2014 by Public Health England and the development of an implementation framework with NHS England, the Department of Health and voluntary bodies to make a step change in the prevention, testing and treatment of hepatitis C.
Blenheim was pleased to see Public Health England’s commitment to take forward the development of a national implementation framework for hepatitis C, drawing on the successes of the Scottish hepatitis C action plan.
John Jolly CEO of Blenheim said:
“Hepatitis C continues to affect a large number of people across the UK, many of whom remain undiagnosed. Hospital admissions, deaths and liver transplants attributable to hepatitis C, continue to rise. It is an outrage that only around 3% of those with long term infection are starting treatment each year.”
- Every day six or seven people are admitted to hospital as a result of untreated hep C (2390 people a year)
- Every day one person dies a premature death as a result of cancer or cirrhosis of the liver caused by hep C 428 people a year
- Every three days someone has a liver transplant as a result of cancer or cirrhosis of the liver caused by hep C 128 people a year
Hepatitis C is disease of inequality and the lack of treatment a clear example of discrimination against marginalised groups.
- 50% of people who inject drugs carry the hepatitis C virus, compared to 0.4% of the UK population as a whole.
- South Asians and Eastern Europeans make up 25% and 23% respectively of virus-carrying people who attempt to donate blood. These blood donors tend to be unaware of their infection.
Blenheim is a member of the Hepatitis C Coalition, The London Working Party on Hepatitis C, and is working in partnership with the Hepatitis C Trust. The organisation is committed to improving treatment for all those with hepatitis C by both campaigning and delivering services on the ground. Read more about our campaign here.